Loading clinical trials...
Loading clinical trials...
Mesh Augmented Reinforcement of Abdominal Wall Suture Line in Patients Undergoing Midline Laparotomy to Limit the Rate of Incisional Hernia Occurrence
The purpose of this prospective, pivotal, multi-center, single-arm, pre-market, investigational clinical study is to assess the safety and performance of Deternia™ Self-Gripping Resorbable Mesh when used for suture line reinforcement after midline laparotomy in clean and clean-contaminated fields (CDC Classification I and II). Data from this study will be used to support market applications. The indication under investigation is reinforcement of midline laparotomy to limit the rate of incisional hernia (IH) in clean and clean-contaminated surgeries (CDC Classification I and II).
The primary objective of this investigation is to evaluate the performance of Deternia™ Self-Gripping Resorbable Mesh when used for suture line reinforcement after elective midline laparotomy in clean and clean-contaminated fields (CDC Classification I and II) at 12 months post-operatively and to demonstrate expected performance in terms of rate of IH occurrence relative to a performance goal (based on historical data on primary laparotomy incision suture closure with small bites only). The secondary objectives are to evaluate the safety and performance of Deternia™ Self-Gripping Resorbable Mesh when used for suture line reinforcement after elective midline laparotomy in clean and clean contaminated fields (CDC Classification I and II) within 36 months postoperatively.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Clinical Hospital Center Sisters of Mercy
Zagreb, Croatia
University Hospital Center of Zagreb
Zagreb, Croatia
Klinikum Braunschweig
Braunschweig, Germany
Pius-Hospital Medical Campus University of Oldenburg
Oldenburg, Germany
Barmherzige Brüder Regensburg
Regensburg, Germany
IJsselland Ziekenhuis
Capelle aan den IJssel, Netherlands
Maastricht University Medical Center
Maastricht, Netherlands
Consorci Sanitari de l'Anoia Hospital Universitari d'Igualada
Igualada, Barcelona, Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Hospital Universitario Ramón y Cajal
Madrid, Spain
Start Date
November 22, 2022
Primary Completion Date
May 1, 2026
Completion Date
September 1, 2028
Last Updated
November 19, 2025
123
ACTUAL participants
Self-Gripping Resorbable Mesh
DEVICE
Lead Sponsor
Medtronic - MITG
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05599750